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Mutations in TBX5, a T-box–containing transcription factor, cause cardiac and limb malformations in individuals
with Holt-Oram syndrome (HOS). Mutations that result in haploinsufficiency of TBX5 are purported to cause
cardiac and limb defects of similar severity, whereas missense mutations, depending on their location in the T box,
are thought to cause either more severe heart or more severe limb abnormalities. These inferences are, however,
based on the analysis of a relatively small number of independent cases of HOS. To better understand the relationship
between mutations in TBX5 and the variable expressivity of HOS, we screened the coding and noncoding regions
of TBX5 and SALL4 for mutations in 55 probands with HOS. Seventeen mutations, including six missense mutations
in TBX5 and two mutations in SALL4, were found in 19 kindreds with HOS. Fewer than 50% of individuals with
nonsense or frameshift mutations in TBX5 had heart and limb defects of similar severity, and only 2 of 20 individuals
had heart or limb malformations of the severity predicted by the location of their mutations in the T box. These
results suggest that neither the type of mutation in TBX5 nor the location of a mutation in the T box is predictive
of the expressivity of malformations in individuals with HOS.
Introduction
Congenital heart defects are the most frequent birth defect
observed in humans and the most common cause of death
in infancy (Guyer et al. 1998). Although the etiology of
most heart defects is unknown, many of them are thought
to have a genetic basis (Burn et al. 1998; Loffredo 2000).
Consequently, understanding the molecular basis of heart
malformations has been a major focus of biomedical re-
search over the past decade. To this end, investigators
have sought to gain insights about the genetic etiology of
cardiac malformations by identifying genes underlying
rare, Mendelian syndromes in which heart defects are a
major feature. A prototypical example of such a con-
dition is Holt-Oram syndrome (HOS [MIM 142900]),
a disorder characterized by limb as well as heart mal-
formations. Most individuals with HOS have either a
secundum atrial septal defect (ASD) or a ventricular sep-
tal defect (VSD), although many other cardiac malfor-
mations have been reported, ranging from mitral valve
prolapse to hypoplastic left heart (Newbury-Ecob et al.
1996; Sletten and Pierpont 1996; Bruneau et al. 1999).
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In 1997, HOS was discovered to be caused by muta-
tions in TBX5 (Basson et al. 1997; Li et al. 1997), one
of a family of transcription factors, called “T-box” genes,
that have been associated with a variety of malfor-
mations (Bamshad et al. 1997; Braybrook et al. 2001;
Merscher et al. 2001). Most of the mutations in TBX5
were predicted to encode, if translated, a truncated pro-
tein that lacked a functional DNA-binding domain.
These mutations often were found in individuals in
whom the heart and limbs were affected with similar
severity. This led to the inference that most cases of
HOS were caused by haploinsufficiency of TBX5, which,
in turn, disrupted both limb and heart development to
a similar extent.
In several kindreds with HOS, individuals who had
heart and limb defects of disparate severity were found
to have missense mutations, suggesting that, in some
cases, HOS might be caused by a dominant-negative
mechanism (Basson et al. 1994, 1997). This observation
led to the proposal that missense mutations predicted
to disturb different regions of the T box might be as-
sociated with organ-specific defects (Basson et al. 1999).
Specifically, an amino acid substitution in the N-ter-
minal end of the T box (i.e., Gly80Arg), predicted to
affect TBX5 binding to the major groove of target DNA,
was found to cause severe heart malformations but rel-
atively mild limb defects in a single, large kindred. Al-
ternatively, two amino acid substitutions in the C-ter-
minal end of the T box (Arg237Gln and Arg237Trp),
which were predicted to perturb TBX5 binding to the
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minor groove of target DNA, were found to cause mild
cardiac abnormalities but severe limb defects.
These findings suggested that TBX5 genotypes might
be predictive of the expressivity of HOS, a compelling
interpretation for several reasons. First, it implied that
different regions of the T box might impart functional
specificity to TBX5 (Schneider and Schwartz 1999). This
inference was reinforced by transactivation studies that
demonstrated that Tbx5 mutants with a Gly80Arg sub-
stitution associated with severe heart malformations
failed to activate atrial natriuretic factor (ANF), whereas
Tbx5 mutants with an Arg237Gln substitution activated
ANF to a level similar to wild-type Tbx5 (Hiroi et al.
2001). Second, it suggested that genetic counseling of
individuals with HOS might be facilitated by making
inferences about anticipatory guidance, based on TBX5
genotypes. Third, it increased the plausibility that some
mutations in the T box of TBX5 might cause isolated
heart malformations, particularly ASDs or VSDs.
For several reasons, it is not clear that TBX5 geno-
types are predictive of the expressivity or the extent of
pleiotropy in HOS. First, all of the study subjects with
HOS caused by a Gly80Arg substitution reported by
Basson et al. (1999) were members of the same kin-
dred, and some of the individuals with Arg237Gln
or Arg237Trp were related to one another. Thus, the
suggested genotype-phenotype correlation was based
on only a few independent cases. Second, only several
other missense mutations in the T box of TBX5 have
been reported to date, and no study has compared TBX5
genotypes to HOS phenotypes in a large cohort of cases.
Third, more recent studies of the DNA-binding char-
acteristics of mutant Tbx5 proteins have demonstrated
that Tbx5 mutants with either the Gly80Arg or the
Arg237Gln substitution failed to bind to a preferred
target DNA sequence identified via an in vitro selection
procedure (Ghosh et al. 2001; Fan et al. 2003). There-
fore, if neither mutant binds the target DNA of TBX5,
it is unclear how missense mutations in different regions
of the T box of TBX5 might cause heart and limb de-
fects of disparate severity.
To further explore the relationship between TBX5
genotypes and HOS phenotypes, we screened the coding
and noncoding regions of TBX5 for mutations in 55
probands with HOS—to our knowledge the largest col-
lection of patients with HOS studied to date. Fourteen
different mutations, including six missense mutations,
were found in 17 kindreds in which affected individuals
spanned the spectrum of HOS phenotypes. We found
no evidence that either the type of mutation or the lo-
cation of a mutation in TBX5 was predictive of the
severity of limb or heart malformations in a patient with
HOS. Only two mutations in TBX5 were found in pro-
bands with phenotypes atypical of HOS (i.e., individ-
uals with heart and limb defects accompanied by physi-
cal findings—e.g., situs inversus—not commonly found
in patients with HOS), and novel mutations in SALL4
were found in an additional two of these atypical cases.
Material and Methods
Clinical Status
All studies were performed with the approval of the
institutional review board of the University of Utah and
the general counsel of the Shriners Hospitals for Chil-
dren. After obtaining informed consent, most living
members of each kindred were evaluated by review of
their medical history, physical examination, radiographs
of the upper limbs, electrocardiogram, and echocardio-
gram. Heart and limb malformations were classified as
mild or severe according to criteria established elsewhere
(Basson et al. 1999). In brief, individuals with unilateral
or bilateral hypoplasia or aplasia of both the humerus
and radius were categorized as having severe limb de-
fects; otherwise, affected individuals were considered to
have mild limb defects. Individuals with multiple sep-
tation defects (e.g., an ASD and a VSD), a single septal
defect plus another cardiac anomaly, or complex con-
genital heart disease were categorized as having severe
heart defects. Individuals with a single septal defect or
only an electrocardiographic abnormality were catego-
rized as having a mild heart defect. All subjects included
in the analysis had normal karyotypes.
Mutation Analysis
Genomic DNA was extracted from peripheral lym-
phocytes through use of standard techniques. DNA se-
quences were amplified using 25 ng genomic DNA as a
template in 1# buffer (1.5 mM MgCl2; 10 mM Tris.Cl,
pH 8.3; 20% Q solution [Qiagen]), 0.5 U QIAGEN
hotstar Taq polymerase, and 10 pmol of each primer.
Samples were cycled 30 times in an MJ Research DNA
Engine Tetrad, using a standard three-step PCR profile
with an initial denaturing step at 94C for 15 min and
a final extension step at 72C for 10 min. Annealing
temperatures and primer sequences can be found in table
A (online only). PCR products were purified by size ex-
clusion or gel extraction using a QIAquick column. Pu-
rified PCR products were sequenced using ABI BigDye
terminator cycle sequencing version 2.0 reagent. Se-
quenced products were loaded on an ABI 377 automated
sequencer and were analyzed by Sequencing Analysis
3.4.1 and SEQUENCHER 4.1 software (Genecodes).
The forward and reverse strand of exons 1–9 of TBX5,
including the flanking splice-recognition sequences, were
analyzed. Complete sequence data were available for 49
of 55 probands.
The presence of each missense and nonsense mutation
was confirmed in each affected individual by either re-
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Figure 1 Pedigrees and electropherograms of 17 families with HOS in which mutations in TBX5 were found. Affected individuals are
denoted by a blackened symbol, unaffected individuals by an unblackened symbol, and unknown phenotypes by a symbol filled with gray.
Numbers below each symbol correspond to the identification numbers in table 1, which is a detailed summary of the clinical findings of each
affected individual. For frameshift mutations, the mutant and wild-type DNA sequences are shown in the top and bottom boxes, respectively.
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striction digestion, performed according to manufactur-
ers’ instructions, or hybridization to an allele-specific
oligonucleotide (see table A [online only]). For each mu-
tation, 150 chromosomes from unrelated, unaffected in-
dividuals from a matched ethnic background were also
screened. Small deletions and insertions were assessed in
at least one affected individual in each kindred by trans-
forming DH5a cells (Invitrogen) with a ligation mixture
containing the PCR-amplified product and pCR2.1 plas-
mid (Invitrogen TA cloning kit). Plasmid DNA was ex-
tracted from 10 transformed clones through use of QIA-
GEN miniprep columns and was subjected to direct
sequencing as described above.
Results
Fourteen different mutations in TBX5 were found in 17
(35%) of 49 probands with putative diagnoses of HOS,
and 12 of these mutations were novel (fig. 1). Either of
two mutations (Thr223Met and Arg237Trp) was found
in five unrelated kindreds with HOS. Mutations were
detected in 9 of 17 familial cases (53%) of HOS, whereas
we were able to identify a mutation in TBX5 in only 8
of 32 sporadic cases (25%). Thus, the rate of detection
in familial cases was approximately twice that in spo-
radic cases.
Six of the mutations found in TBX5 are predicted to
encode a product that, if translated, would be prema-
turely truncated prior to or within the T box (fig. 2).
This includes one nonsense mutation (Ser196Ter) and
five frameshift mutations (100-101insG, 100delG, 400-
401insC, 426-427insC, and 456delC). Since deletion of
even the most C-terminal amino acid residues of the T
box results in loss of TBX5 binding to its consensus
binding sequence in vitro (Ghosh et al. 2001), these
mutations likely represent null alleles. A partial TBX5
protein that includes the T box could be produced in
the presence of either of two mutations, 798delA and
Arg279Ter. However, both proteins would still lack much
of the C-terminal domain of TBX5. The mechanism(s)
by which 798delA and Arg279Ter disrupt the function
of TBX5 is unclear, because deletion of the entire C-
terminal region (amino acids 238–518 inclusive) en-
hances DNA binding affinity, whereas deletion of amino
acids 242 onwards results in loss of binding to the T-
binding element (Ghosh et al. 2001).
Six of the mutations found in TBX5 were missense
mutations, four of which have not been reported pre-
viously. Each of these mutations is predicted to result
in substitution of an amino acid residue of TBX5 that
is highly conserved among species (fig. 3). Five of these
amino acid residues are located within the DNA-binding
domain of TBX5. One predicted amino acid substitu-
tion (Ser261Cys) is in the C-terminal domain of TBX5,
farther downstream of the T box than any missense mu-
tation reported previously. One mutation—Thr223Met,
caused by a missense mutation of a CG doublet—was
found in three unrelated kindreds, suggesting that this
may be a mutational hotspot. Overall, missense mu-
tations were found in ∼50% of the probands in whom
mutations were identified.
Most individuals in whom a mutation in TBX5 was
discovered had a phenotype typical of HOS, although
a wide spectrum of limb and heart malformations was
found both within and between families. A total of 16
individuals had mutations predicted to cause truncation
of TBX5 and, in turn, heart and limb malformations of
similar severity. Although 6 of these individuals had
both mild heart and mild limb defects, 10 individuals
had either more severe heart ( ) or more severenp 6
limb ( ) defects. Moreover, the categorization ofnp 4
phenotypes frequently varied, even within the same kin-
dred. For example, individual I-1 in kindred K2 (fig. 1)
has hypoplasia of the left humerus, radius, and ulna
and absence of the thumb bilaterally (i.e., severe limb
defects) without an accompanying heart defect. In con-
trast, each of his two sons (II-1 and II-2) have multiple
septal defects (i.e., severe heart defects) and unilateral
or bilateral hypoplasia/aplasia of the thumb (i.e., mild
limb defects).
Twenty-three individuals had missense mutations in
TBX5. A Trp121Gly substitution in the N-terminal re-
gion of the DNA-binding domain of TBX5 was found
in five members of a single kindred. This mutation is
predicted to cause severe heart and mild limb defects,
and, although each individual had mild limb malfor-
mations, only one had a severe heart defect (an ASD
and multiple VSDs in individual IV-1). The other four
affected individuals had either a single ASD or no de-
tectable structural defect. Fourteen individuals had mis-
sense mutations in the C-terminal region of the DNA-
binding domain of TBX5 that were predicted to cause
severe limb anomalies and mild cardiac defects. Eight of
these individuals, from three kindreds, had a Thr223Met
substitution. In contrast to the anticipated phenotype,
all eight individuals had mild limb defects, and five of
them had severe heart malformations. Six individuals had
substitutions of amino acid residue 237, only one of
whom had a severe limb anomaly, and two of these
individuals with an Arg237Trp substitution had severe
heart defects. Overall, 8 of 20 individuals with a mis-
sense mutation causing HOS had heart and limb defects
of disparate severity. Only 2 of the 20 affected individu-
als had a pattern of limb and heart malformations con-
sistent with the prediction that mutations in the car-
boxy- and amino-terminal regions of the T box cause
more severe limb and heart malformations, respectively.
The mechanism by which missense mutations in TBX5
cause HOS remains unclear. We found five different
missense mutations in TBX5 that are predicted to
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Figure 2 Schematic of genomic structure of TBX5 (not drawn to scale), indicating the locations of mutations identified to date. The exons
encoding the T box are shaded, and each of the mutations reported in this study is in boldface type. Asterisks (*) denote mutations that have
been found in more than one proband.
cause an amino acid substitution in the T box
(Trp121Gly, Gly195Ala, Thr223Met, Arg237Gln, and
Arg237Trp). To gain further insight into the effect of
these mutations on the function of TBX5, we compared
the predicted structure of TBX5 mutants to wild-type
TBX5 by creating a model of the DNA-binding domain
of TBX5 based on the crystal structure of TBX3 (Coll
et al. 2002). The justification for using TBX3 as a start-
ing point is based, in part, on the observation that the
T-box domains of human TBX3 and TBX5 share 62%
amino acid identity.
The core of the T box consists of a seven-stranded b
barrel, which is closed by a lid structure comprising a
two-stranded b sheet (fig. 4). The protein contacts the
DNA through amino acids located in loops and strands
in the lid and from residues in two perpendicular C-
terminal helices, a helix 3 and helix 310C. TBX5 residue
Trp121 corresponds to TBX3 residue Trp170 in the lid
structure where it packs against the core b barrel (“A”
in fig. 4). The Trp121Gly substitution in TBX5 is pre-
dicted to destabilize the lid structure, which would likely
alter the folding or stability of TBX5 and disrupt pro-
tein-DNA interactions.
TBX5 residue Thr223 corresponds to residue Thr270
in TBX3 (“B” in fig. 4). Thr270 is in a helix 3, where
the side chain contacts DNA phosphate backbone at-
oms, and projects into a relatively open environment in
the major groove. Helix 3 and the preceding loop (resi-
dues 264–268 in TBX3) make important contacts in the
major groove. Their position is determined, in part,
by an important hydrogen bonding network includ-
ing Glu229 (Glu180 in TBX5), which bridges between
the core b barrel and the loop preceding helix 3 (“C”
in fig. 4). Thus, substitution of residue Thr270 or
Trp170 is expected to influence DNA recognition resi-
dues that normally contact the major groove. Thr270
occupies only part of a small void between the protein
and the major groove. Modeling predicts that this space
can accommodate a methionine side chain, suggesting
that alteration in the activity of TBX5 does not result
from steric clashes between a bulky side chain and DNA.
Arg237Gln and Arg237Trp, corresponding to Arg284
in TBX3 (“D” in fig. 4), are predicted to disrupt the
position and stability of the C-terminal a helix, (equiva-
lent to a helix 310C in TBX3 and a helix 4 in Xbra),
thereby affecting binding of TBX5 to the minor groove
of the DNA target (Basson et al. 1999). Gly195 is analo-
gous to Lys242 in TBX3. Lys242 is located within a
short a helix that is not present in the Xbra crystal
structure of the DNA-binding domain of TBX3 (Muller
and Herrmann 1997). This helix is on the surface of
the core region distal to the DNA-binding residues and
is positioned next to a stretch of four amino acid resi-
dues predicted to make weak interactions with a second
TBX3 monomer in complex with the palindromic bind-
ing site. Since the function of this part of the protein
has not been established, we cannot predict the impact
of the Gly195Ala substitution in TBX5. One missense
mutation in TBX5 (Ser261Cys) is downstream of the
T box. A predicted function of this region of TBX5 is
to interact with modifier proteins (Ghosh et al. 2001).
Consequently, this substitution might, if translated
into a stable protein, alter the interaction of TBX5 with
a cofactor.
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Figure 3 Deduced amino acid sequence of partial TBX5 protein in the human, mouse, chicken, and zebrafish. The conserved T-box region
is shaded. Missense mutations are indicated in boldface type.
Two individuals with mutations in TBX5 had findings
atypical of HOS: abdominal situs inversus in one in-
dividual (II-1 in kindred K7), and cleft palate, micro-
gnathia, and facial asymmetry in another (III-3 in kin-
dred K14). These facial abnormalities are, in particular,
uncommon in HOS (Allanson and Newbury-Ecob 2003).
Interestingly, in the latter case, HOS was caused by a
Ser261Cys substitution downstream of the DNA-bind-
ing domain of TBX5, in a region whose function is
unknown. However, other affected individuals in kin-
dred K14 also had atypical findings, such as hypoplastic
distal phalanges and fingernails, and a sib without a
mutation in TBX5 had thin hair and hypoplastic teeth.
Thus, it is possible that two etiologically distinct dis-
orders are segregating in this family.
Of the remaining 32 kindreds in which mutations in
the noncoding and coding regions of TBX5 were not
found, haplotype analysis could not exclude TBX5, and
no pedigree provided enough statistical power to in-
dependently establish linkage to another locus. Some
of the affected individuals in these kindreds had defects
that are uncommon in HOS (e.g., imperforate anus
and truncus arteriosus), suggesting that the etiology of
heart and limb malformations in our cohort might be
heterogeneous.
Fanconi anemia and Okihiro syndrome (MIM
607323) can be challenging to distinguish from HOS.
Okihiro syndrome is thought to be distinguished from
HOS by the presence of Duane anomaly, which includes
an external ophthalmoplegia. However, Duane anomaly
has a variable age of presentation and can be difficult
to detect in the absence of a complete ophthalmological
exam. Because Okihiro syndrome has recently been
found to be caused by mutations in SALL4 (Kohlhase
et al. 2002), we screened the four exons of SALL4 in
29 of the remaining kindreds with HOS and discovered
two novel mutations (see fig. A [online only]). One mu-
tation, in an individual with sporadic disease, was a
GrA missense mutation that causes a Val752Met sub-
stitution. This mutation was not found on 230 control
chromosomes. However, one parent had the same mu-
tation, but no phenotypic information about this parent
was available. Therefore, it is unclear whether this vari-
ant is the definitive cause of HOS in this individual. The
other mutation identified was a 4-bp insertion that
causes a frameshift in SALL4 in a mother and her son.
Only one of these three individuals with a mutation in
SALL4 had an ophthalmoplegia.
Discussion
When our results are included, a total of 35 different
mutations in TBX5 have been found to cause HOS (Bas-
son et al. 1997, 1999; Li et al. 1997; Cross et al. 2000;
Yang et al. 2000; Akrami et al. 2001; Huang 2002).
These include missense, nonsense, frameshift, and splice-
site mutations; a deletion encompassing exons 3–9 (Ak-
rami et al. 2001); and a translocation that putatively
disrupts TBX5 (Basson et al. 1997). The Arg279Ter mu-
tation, found in a total of six familial and sporadic cases
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Figure 4 Ribbon diagram of TBX3/TBX5, shown in turquoise, interacting with DNA, shown as a space-filling model in shades of gray.
Important side chains are shown as ball-and-stick models, colored by atom type. Hydrogen bond interactions are shown as dashed orange lines.
Perturbations of TBX5 introduced by missense mutations are indicated by A, B, C, and D (see text for details). The TBX5 model is based on
the crystal structure of TBX3 from Swiss Prot deep view (Coll et al. 2002). Atomic coordinates for the structure of a TBX3-DNA complex
(Protein Database entry 1H6F) were used to create a homology model of TBX5 in complex with DNA. Model manipulations, including changes
to the identity and positions of amino acid side chains and examination of hydrogen-bonding networks, were performed with the molecular
graphics program O (Jones et al. 1991). Mutations were modeled by changing the relevant amino acid side chains and exploring standard side
chain rotamer positions for steric clashes. Atomic figures were generated with the programs MOLSCRIPT (Kraulis 1991) and Raster3D (Merritt
and Murphy 1994; Merritt and Bacon 1997).
of HOS, is caused by a CrT transition at bp 1500 that
is part of a CG doublet. Accordingly, this site may rep-
resent a mutation hotspot in TBX5. Three missense mu-
tations (Thr223Met, Arg237Gln, and Arg237Trp) and
two nonsense mutations (Ser196Ter and Arg279Ter) ac-
count for ∼50% of all mutations found thus far in TBX5.
TBX5 mutations were found in only ∼30%–35% of
sporadic and familial cases meeting the diagnostic cri-
teria for HOS. This is similar to the summarized results
of previous surveys of patients who have received di-
agnoses of HOS (Cross et al. 2000). There are several
possible explanations for the low detection rate of mu-
tations. First, some individuals with diagnoses of HOS
might be phenocopies, particularly because sporadic
heart and limb defects are common, and many of the
putative HOS pedigrees were uninformative for linkage
analysis. This is supported by the higher mutation de-
tection rate in familial compared with sporadic cases in
our cohort. Second, in most studies, only the coding
regions of TBX5 have been screened for mutations.
Thus, large deletions or mutations in noncoding regions
that might disrupt the expression of TBX5 function
would not be detected. However, a search for large de-
letions in 20 cases of HOS in which no mutations in
TBX5 had been found yielded only one new mutation
(Akrami et al. 2001). Similarly, screening the UTRs of
TBX5 did not increase our detection rate. Third, HOS
may be a genetically heterogeneous disorder. This is con-
sistent with the observation that HOS does not map to
12q24 in some pedigrees (Terrett et al. 1994), although
no additional loci have been identified. Finally, there
may be regulatory regions important for normal TBX5
expression that have yet to be identified and that may
harbor mutations causing HOS. None of these expla-
nations are mutually exclusive, and each may, in part,
be responsible for the low rate of detection of mutations
in TBX5.
We found no evidence that either the type of mutation
or the location of a mutation in TBX5 was predictive
of the severity of limb or heart malformations in an
individual with HOS. Most individuals with mutations
predicted to truncate TBX5 did not exhibit heart and
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limb defects of similar severity. Moreover, the position
of an amino acid substitution in the DNA-binding do-
main of TBX5 was not predictive of the severity of either
the heart or the limb malformations. This result is, how-
ever, dependent on the definition of a mild versus a
severe malformation. Although we used the classifica-
tion of Basson et al. (1999) to score severity, the bio-
logical justification of this scheme is unclear. For example,
it may not be meaningful, in either a clinical or devel-
opmental context, to consider absence of the hand and
forearm as a mild limb defect while hypoplasia of the
thumb, radius, and humerus is considered a severe mal-
formation. Unfortunately, any such dichotomization of
limb and heart defects is arbitrary, and, if we reanalyze
the HOS phenotypes in our cohort by classifying each
malformation separately (e.g., ASD, VSD, triphalangeal
thumb, or hypoplastic thumb), TBX5 genotypes are still
not predictive of the type of heart or limb malformation.
An accurate estimate of genotype-phenotype relation-
ships in HOS would be a powerful resource for further
exploring the molecular and developmental mechanisms
underlying normal cardiac and limb development and
for improving the clinical care for patients with HOS.
However, this is a challenging objective for any rare
malformation syndrome, including HOS. This is due,
in part, to the small number of independent cases avail-
able for statistical analysis. The size of the sample often
is limited further because rare malformation syndromes
typically are caused by many different mutations. Infer-
ences about genotype-phenotype relationships for such
conditions could be corroborated by data from model
organisms. Yet, even highly inbred strains of model or-
ganisms with disruptions of genes that cause human
malformation syndromes (e.g., see Bruneau et al. 2001)
often exhibit widely variable phenotypes. This under-
scores the substantial degree of environmental and/or
stochastic variation that influences the expressivity of
many malformation syndromes.
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